Literature DB >> 21093224

Cerebral metabolic responses to 5-HT2A/C receptor activation in mice with genetically modified serotonin transporter (SERT) expression.

Neil Dawson1, Linda Ferrington, Klaus-Peter Lesch, Paul A T Kelly.   

Abstract

Variation in the human serotonin transporter gene (hSERT; 5-HTT) resulting in a life-long alteration in SERT function influences anxiety and the risk of developing affective disorders. The mechanisms underlying the influence of the hSERT gene on these phenotypes remain unclear but may involve altered 5-HT receptor function. Here we characterise the cerebral metabolic response to 5-HT(2A/C) receptor activation in two transgenic mouse models of altered SERT function, SERT knock-out (SERT KO) and hSERT over-expressing (hSERT OE) mice, to test the hypothesis that genetically mediated variability in SERT expression alters 5-HT(2A/C) function. We found that a constitutive increase in SERT expression (hSERT OE) enhanced, whereas a constitutive decrease in SERT expression (SERT KO) attenuated, 5-HT(2A/C) function. Therefore, altered 5-HT(2A/C) receptor functioning in response to hSERT gene variation may contribute to its influence on affective phenotypes.
Copyright © 2010 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21093224     DOI: 10.1016/j.euroneuro.2010.10.006

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  7 in total

1.  A mouse model to address unresolved antidepressant issues.

Authors:  Judith R Homberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-18       Impact factor: 11.205

2.  Subanesthetic ketamine treatment promotes abnormal interactions between neural subsystems and alters the properties of functional brain networks.

Authors:  Neil Dawson; Martin McDonald; Desmond J Higham; Brian J Morris; Judith A Pratt
Journal:  Neuropsychopharmacology       Date:  2014-02-04       Impact factor: 7.853

3.  Serotonin 5-HT1B receptor-mediated behavior and binding in mice with the overactive and dysregulated serotonin transporter Ala56 variant.

Authors:  Kally C O'Reilly; Michelle Connor; Jamie Pierson; Lauren C Shuffrey; Randy D Blakely; Susanne E Ahmari; Jeremy Veenstra-VanderWeele
Journal:  Psychopharmacology (Berl)       Date:  2021-01-29       Impact factor: 4.530

4.  Chronic activation of corticotropin-releasing factor type 2 receptors reveals a key role for 5-HT1A receptor responsiveness in mediating behavioral and serotonergic responses to stressful challenge.

Authors:  Adi Neufeld-Cohen; Paul A T Kelly; Evan D Paul; Roderick N Carter; Elizabeth Skinner; Henry J Olverman; Joan M Vaughan; Orna Issler; Yael Kuperman; Christopher A Lowry; Wylie W Vale; Jonathan R Seckl; Alon Chen; Pauline M Jamieson
Journal:  Biol Psychiatry       Date:  2012-06-15       Impact factor: 13.382

5.  The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders.

Authors:  Jocelien D A Olivier; Christiaan H Vinkers; Berend Olivier
Journal:  Front Pharmacol       Date:  2013-06-11       Impact factor: 5.810

6.  Increased anxiety in corticotropin-releasing factor type 2 receptor-null mice requires recent acute stress exposure and is associated with dysregulated serotonergic activity in limbic brain areas.

Authors:  Orna Issler; Roderick N Carter; Evan D Paul; Paul At Kelly; Henry J Olverman; Adi Neufeld-Cohen; Yael Kuperman; Christopher A Lowry; Jonathan R Seckl; Alon Chen; Pauline M Jamieson
Journal:  Biol Mood Anxiety Disord       Date:  2014-01-21

7.  Serotonin Transporter Binding in the Diencephalon Is Reduced in Insulin-Resistant Obese Humans.

Authors:  Ruth I Versteeg; Karin E Koopman; Jan Booij; Mariëtte T Ackermans; Unga A Unmehopa; Eric Fliers; Susanne E la Fleur; Mireille J Serlie
Journal:  Neuroendocrinology       Date:  2016-09-14       Impact factor: 4.914

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.